Skip to content
OpenCapital
Get started

Protara Therapeutics, Inc. TARA Q1 2026 earnings

Reported May 13, 2026 · Before market open

EPS-$0.31Beat by $0.05
EPS estimate-$0.36

Next report

Aug 10, 2026 (In 1 week)
EPS estimate-$0.33

Versus estimates

Diluted EPS

Q1 2026-$0.31Beat by $0.05
Q4 2025-$0.37Miss by $0.05Q3 2025-$0.31Beat by $0.08Q2 2025-$0.35Beat by $0.08Q1 2025-$0.29Beat by $0.18Q4 2024-$0.48Beat by $0.09

Ask the moment Protara Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Protara Therapeutics, Inc. report Q1 2026 earnings?
Protara Therapeutics, Inc. (TARA) reported Q1 2026 earnings on May 13, 2026 before market open.
What were Protara Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Protara Therapeutics, Inc. reported eps of $-0.31 for Q1 2026.
Did Protara Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.36 by $0.05.
How did Protara Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 6.9% from $-0.29.
Where can I find Protara Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001213900-26-055462) and the 10-Q periodic report (0001213900-26-055463) directly on SEC EDGAR. The filing index links above go to sec.gov.